Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020

Wearables and Mobile Technologies Growth Opportunities in Digital Transformation Journey of Clinical Trials

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
17-May-2018
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K2B4-01-00-00-00
SKU
LS00281-NA-MR_21910
Yes
SHARE

Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020
Published on: 17-May-2018 | SKU: LS00281-NA-MR_21910

Need more details?

$3,000.00

$2,250.00 save 25 %

DownloadLink
Need more details?

Clinical trial sponsors and clinical research organizations (CROs) are facing intense pressure to change the way clinical research is conducted and justify the costs and time involved in the clinical development process. Some of the prevailing challenges in the clinical trial industry include the complexity and cost of conducting clinical trials, the failure of trials, increasing regulatory requirements for future targeted therapeutics, and the growing number of multi-regional and international trials. Among these, patient recruitment and monitoring activities are considered to be most cost and time-consuming aspect of the clinical trial process. Industry estimates suggest that about 80% of pharmaceutical clinical trials do not meet enrolment deadlines, resulting in an average loss of up to $1.3 million per day for a given drug candidate. Additionally, up to 37% of research sites fail to meet their enrolment targets, and 10% fail to even recruit a single patient for the study.

Digitization is playing a critical role in transforming clinical trials model from traditional (centralized) high-cost and difficult-to-access settings to more patient-centric and efficient virtual models. In particular, pharmaceutical companies are seeking to leverage mHealth solutions—embracing digital technologies such as wearables, smartphone Apps, and cloud-based remote/virtual clinical trial platform solutions—for improving patient engagement, preventing trial failures, and, overall, improving the drug development profitability. Early application of wearable devices and smartphone apps across remote or virtual clinical trial designs demonstrate compelling benefits around optimizing the patient recruitment process by opening up new geographies to increase access to the larger patient population and reduce trial costs by streamlining the trial processes and demonstrating real-world efficacy. Digital e-Recruitment solutions leveraging mHealth technologies and innovative crowdsourcing models promise to drive efficiency and optimize the patient enrichment strategy for future patient-centric clinical trials. This, in turn, would help to improve patient engagement with autonomous and digital workflows (e.g., eConsenting, remote monitoring, virtual training, and reminders) that reduce the burden on the patient and the caregiver. Furthermore, based on research findings, clinical trials industry participants across North America and Europe will continue to the major markets for mHealth technologies application in the clinical trial industry by 2020. Easy access and convenience factors offered by mHealth-enabled remote trials could significantly reduce patients’ travel cost to the sites as they could now participate from their homes using computers and smartphones, eventually improving retention. mHealth technologies provide new possibilities to capture objective digital biomarker data, increase the reporting quality of clinical trials, and reduce SDV by eliminating errors due to with traditional paper-based reporting by patients or investigators.

Research Scope

The research service analyzes the growth opportunities of mHealth technologies across clinical trial remote patient recruitment & monitoring applications. It also evaluates and discusses market projections, key trends, technology lifecycle, and the key implementation challenges of emerging digital solutions. Finally, it provides industry best practices, case studies, cost-benefit analysis, and strategic imperatives for key clinical trial industry stakeholders such as pharma sponsors, CRO, sites, and technology providers.

Key Issues Addressed

  • What are the key trends and growth opportunities tied to emerging digitally-led clinical trials operating models (e.g., remote or virtual clinical trials)?
  • Which emerging tech solutions have the strongest growth potential for optimizing patient recruitment and monitoring workflows (e.g., mHealth, Wearables, etc.)?
  • What are the challenges with current clinical trial patient recruitment and monitoring workflows and how these can be filled by emerging digital health solutions?
  • How does the new ecosystem of digital solution providers look like with specific reference to clinical trials patient recruitment and monitoring?
  • What are the industry best practices for patient recruitment, trial management etc.?
  • What are the key challenges while implementing these digital solutions across the clinical development value chain?

Six Big Themes—Clinical Trial and Development Digitization

mHealth Ecosystem Solutions—Promoting Patient-centric Trials

Clinical Trial Digitization—Top 3 Growth Opportunities

Key Questions this Study will Answer

Market Definition—Clinical Trials and Development IT Solutions

Clinical Trials Patient Recruitment and Monitoring IT Solutions—Major Segments by Technology and System Types

Emerging Vendor Ecosystem—Clinical Trials Patient Recruitment and Monitoring IT Solutions

Six Big Themes—Clinical Trial and Development Digitization

Patient Recruitment Challenges

Focus on Patient Centricity—Case Examples

Evolving Clinical Trial Models

Evolving Clinical Trials Models for Precision Oncology Therapeutics

Clinical Trial Patient Enrichment Strategies and Case Studies

Entry of Non-traditional Players

Digital Continuity—IT Solutions Adoption Potential

Technology Lifecycle for Select Clinical Development IT Solutions

mHealth Technologies Category Definition

mHealth Ecosystem Solutions—Promoting Patient-centric Trials

Growth Opportunity—mHealth Solutions

mHealth Solutions Implications across Clinical Trial Value Chain

Current Challenges and Role of mHealth Solutions

Revenue Forecast—mHealth Solutions: Wearables and Smartphones

Forecast Assumptions for the mHealth Solutions Market

Forecast Assumptions—Key Trends for Clinical Trials mHealth Market

Forecast Assumptions—Key Trends for Clinical Trials mHealth Market (continued)

mHealth Technologies Adoption Trends in Commercial Clinical Trials

mHealth Application for Developing Novel Endpoints for Clinical Trials

mHealth-based Remote Trials—Potential Cost-Saving Opportunities

Evolving Clinical Trial Patient Recruitment Strategies

Clinical Trial e-Recruitment Solutions Market Overview

Select Case Studies—How mHealth Solutions Optimize Patient Recruitment and Retention for Clinical Trials?

MolecularMatch—Democratizing Cancer Clinical Trial Patient Recruitment

Antidote Technologies, Inc—Democratizing the Clinical Trial Process

patientslikeme—Online Patient Social Network (US)

Clinical Trial Enrichment—Technology Select Start-ups

Evolving Clinical Trial Models

Clinical Trials Remote/Virtual Monitoring Solutions Market Overview

Case Study—VERKKO: First Remote Clinical Study in Europe

Case Study—mHealth Enabled Companion Digital Therapy

Science 37 + AOBiome LLC—Virtual Trial Microbiome Acne Treatment

Science 37—Expanding Pharma Sponsor Collaborations

Select Case Studies—How mHealth Solution Optimizes Patient Reporting and Engagement?

Aparito—Remote Patient Monitoring for Pediatrics and Orphan Diseases (UK)

Evidation Health—SaaS platform for Behaviour-focused Studies

Strategic Imperatives for Key Industry Stakeholders

eClinical Solutions Convergence Potential with Emerging Technologies

Clinical Trials Internet of Things (IoT) Ecosystem—2025

Blockchain—Potential Impact across Drug Development Value Chain

Biometrics that Can be Tracked by Wearable Technologies

Partnering to Innovate—Beyond Conventional Boundaries

Key Challenges for Implementing Digital Solutions for Clinical Trial Remote Patient Recruitment and Monitoring

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Clinical trial sponsors and clinical research organizations (CROs) are facing intense pressure to change the way clinical research is conducted and justify the costs and time involved in the clinical development process. Some of the prevailing challenges in the clinical trial industry include the complexity and cost of conducting clinical trials, the failure of trials, increasing regulatory requirements for future targeted therapeutics, and the growing number of multi-regional and international trials. Among these, patient recruitment and monitoring activities are considered to be most cost and time-consuming aspect of the clinical trial process. Industry estimates suggest that about 80% of pharmaceutical clinical trials do not meet enrolment deadlines, resulting in an average loss of up to $1.3 million per day for a given drug candidate. Additionally, up to 37% of research sites fail to meet their enrolment targets, and 10% fail to even recruit a single patient for the study. Digitization is playing a critical role in transforming clinical trials model from traditional (centralized) high-cost and difficult-to-access settings to more patient-centric and efficient virtual models. In particular, pharmaceutical companies are seeking to leverage mHealth solutions—embracing digital technologies such as wearables, smartphone Apps, and cloud-based remote/virtual clinical trial platform solutions—for improving patient engagement, preventing trial failures, and, overall, improving the drug development profitability. Early application of wearable devices and smartphone apps across remote or virtual clinical trial designs demonstrate compelling benefits around optimizing the patient recruitment process by opening up new geographies to increase access to the larger patient population and reduce trial costs by streamlining the trial processes and demonstrating real-world efficacy. Digital e-Recruitment solutions leveraging mHealth technologies and innovative crowdsourcing model
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Kamaljit Behera
WIP Number K2B4-01-00-00-00
Keyword 1 North American Mobile
Is Prebook No
GPS Codes 9562-B1,9568-B1,9600-B1,9611-B1,9627-B1,9A43-B1,9A44-B1

Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020

$3,000.00

Special Price $2,250.00 save 25 %

In stock
SKU
LS00281-NA-MR_21910